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Abstract
Background: This study evaluated the dosimetric impact of various treatment techniques as well
as collimator leaf width (2.5 vs 5 mm) for three groups of tumors – spine tumors, brain tumors
abutting the brainstem, and liver tumors. These lesions often present challenges in maximizing dose
to target volumes without exceeding critical organ tolerance. Specifically, this study evaluated the
dosimetric benefits of various techniques and collimator leaf sizes as a function of lesion size and
shape.
Methods: Fifteen cases (5 for each site) were studied retrospectively. All lesions either abutted
or were an integral part of critical structures (brainstem, liver or spinal cord). For brain and liver
lesions, treatment plans using a 3D-conformal static technique (3D), dynamic conformal arcs
(DARC) or intensity modulation (IMRT) were designed with a conventional linear accelerator with
standard 5 mm leaf width multi-leaf collimator, and a linear accelerator dedicated for radiosurgery
and hypofractionated therapy with a 2.5 mm leaf width collimator. For the concave spine lesions,
intensity modulation was required to provide adequate conformality; hence, only IMRT plans were
evaluated using either the standard or small leaf-width collimators.
A total of 70 treatment plans were generated and each plan was individually optimized according
to the technique employed. The Generalized Estimating Equation (GEE) was used to separate the
impact of treatment technique from the MLC system on plan outcome, and t-tests were performed
to evaluate statistical differences in target coverage and organ sparing between plans.
Results: The lesions ranged in size from 2.6 to 12.5 cc, 17.5 to 153 cc, and 20.9 to 87.7 cc for the
brain, liver, and spine groups, respectively. As a group, brain lesions were smaller than spine and
liver lesions. While brain and liver lesions were primarily ellipsoidal, spine lesions were more
complex in shape, as they were all concave. Therefore, the brain and the liver groups were
compared for volume effect, and the liver and spine groups were compared for shape. For the brain
and liver groups, both the radiosurgery MLC and the IMRT technique contributed to the dose
sparing of organs-at-risk(OARs), as dose in the high-dose regions of these OARs was reduced up
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to 15%, compared to the non-IMRT techniques employing a 5 mm leaf-width collimator. Also, the
dose reduction contributed by the fine leaf-width MLC decreased, as dose savings at all levels
diminished from 4 – 11% for the brain group to 1 – 5% for the liver group, as the target structures
decreased in volume. The fine leaf-width collimator significantly improved spinal cord sparing, with
dose reductions of 14 – 19% in high to middle dose regions, compared to the 5 mm leaf width
collimator.
Conclusion:  The fine leaf-width MLC in combination with the IMRT technique can yield
dosimetric benefits in radiosurgery and hypofractionated radiotherapy. Treatment of small lesions
in cases involving complex target/OAR geometry will especially benefit from use of a fine leaf-width
MLC and the use of IMRT.
Background
Stereotactic intracranial radiosurgery (SRS) and extracra-
nial body radiosurgery and radiotherapy (SBRT) are char-
acterized by ablative, high dose irradiation of target
structures. Complex targets, such as spine metastases,
brain lesions abutting the brain stem, and liver lesions
present challenges in maximizing the dose to the target
volume while not exceeding the critical organ tolerances
[1-20]. This study evaluates the benefits of a dedicated
radiosurgery system with a fine leaf-width collimator for
these different groups of patients. More specifically, this
study evaluates the dosimetric benefits of this system as a
function of target size and shape complexity.
Materials and methods
Patient Data
This retrospective study included 15 cases (5 each for
brain, liver and spine sites) treated with SRS/SBRT at our
institution. As shown in Additional file 1, these lesions
ranged in size from 2.6 – 12.5 cc, 17.5 – 153.1 cc, and 20.9
– 87.7 cc for the brain, liver, and spine groups, respec-
tively. The volumes selected were intended to represent
the ranges of the target volumes typically encountered for
these sites. The selected cases all involved lesions next to
or within critical structures, i.e., lesions next to the brain-
stem for the brain group, lesions within the liver for the
liver group, and tumors near/abutting the spinal cord for
the spine group. The brain and liver lesions were mostly
ellipsoidal, with brain lesions having smaller volumes.
The spine lesions were more complex in shape, as they
were all concave; volumes were similar to the liver lesions.
Therefore, the brain and the liver groups were compared
for volume effect and the liver and the spine groups were
compared for shape effect. Figure 1 displays the rendering
of the target volumes and critical structures in 3D space
for these three sites.
Treatment planning
Treatment plans were designed with the Novalis Tx radio-
surgery system (BrainLab AG, Munich, Germany and Var-
ian Medical Systems, Palo Alto, CA) versus the standard
Varian 2100Clinac system (Varian Medical Systems, Palo
Alto, CA), which served as the baseline for comparison.
The Novalis Tx radiosurgery system became commercially
available in early 2008, and was equipped with a newly
designed micro-mulitleaf collimator (HD120 MLC) sys-
tem, replacing the standard Millennium MLC system. In
contrast to previous micro-MLC systems [2,21-24], the
Novalis Tx radiosurgery MLC is within the gantry housing,
instead of being an add-on tertiary system [2,21-24]. The
mounting of an add-on tertiary MLC not only prolongs
the treatment procedure, but also reduces the clearance
between the gantry and couch, therefore limiting the free-
dom to select certain beam angles. The Novalis Tx HD120
MLC has 32 leaf pairs in the center, each a with leaf width
of 2.5 mm (projected at the isocenter) and 14 leaf pairs on
each side (a total of 28) with a leaf width of 5 mm; thus,
the total number of leaves is 120. Our initial measure-
ments also showed a sharper penumbra. The HD120 MLC
leaf side penumbra was 2.5 mm vs. 2.8 mm with the
standard MLC, and the HD120 MLC leaf end penumbra
was 2.8 mm vs. 3.6 mm with the standard MLC[25]. For
conformal static treatment (3D) and dynamic conformal
arc treatment (DARC) treatments, the maximum dose rate
with the Novalis Tx system is 1000 MU/min versus 600
MU/min with the Clinac system, allowing faster radiation
delivery.
For each case, the normal structures and OARs were con-
toured by a physician with expertise in SRS/SBRT. The tar-
get volumes were contoured by the same physician. For
the brain lesions, the planning target volume (PTV) was
generated by expanding the contrast-enhancing T1-
weighted MRI volume by 1-mm, except at the junctions of
the tumor and brainstem where no expansion was added.
The liver lesions were treated with deep inhale breath-
hold technique and cone-beam CT (CBCT) guidance, and
the PTV was obtained by expanding the lesion volume by
5 mm right-left and anterior-posterior and 7 mm supe-
rior-inferior. The PTV expansion for spine lesions was also
non-uniform, usually 3 mm except at the lesion and cord
interface, where 0 – 1 mm expansion was used.Radiation Oncology 2009, 4:3 http://www.ro-journal.com/content/4/1/3
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Treatment plans were generated using three techniques:
3D, DARC, and IMRT. For the brain and liver lesions,
plans using all three techniques were designed. For each
lesion and planning technique, plans were generated
using both the standard MLC and the HD120 MLC. All
the spine lesions exhibited concave shapes, and the 3D
and the DARC techniques could not provide clinically
adequate conformality. Hence, only IMRT plans were gen-
erated for the spine lesions, again using both the standard
MLC and HD120 MLC. Typically, the 3D plans used 6–12
beams, DARC plans used 4 – 7 arcs and IMRT plans used
4–12 static beams. The multiple arcs for the brain lesions
were mainly designed to take advantage of different couch
angles and those for the liver lesions utilized different
Examples of lesions and adjacent critical structures/organs for the brain (a), the liver(b), and the spine (c) groups Figure 1
Examples of lesions and adjacent critical structures/organs for the brain (a), the liver(b), and the spine (c) 
groups. The 3D rendering of the geometrical relationships is shown in (d) for the brain case (left), liver case (middle) and 
spine case (right).Radiation Oncology 2009, 4:3 http://www.ro-journal.com/content/4/1/3
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beam weightings through different sections of anatomy.
Each plan was individually optimized according to the
treatment techniques selected. Beam angles (non-copla-
nar or coplanar) were chosen to minimize doses to the
critical structures and to achieve high dose fall-off around
the target at the same time. For IMRT planning, planning
objectives included dose uniformity to the PTV and dose
constraints for the OARs as well as dose falloff at the target
boundary. For each plan, 90% of the prescription dose
covered at least 97% of the PTV.
In summary, a total of 70 treatment plans were designed
and each plan was individually optimized according to
the technique employed. For the purpose of the dosimet-
ric analysis in this study, the prescription dose was set to
a nominal 12.5 Gy in a single fraction for the brain
lesions, three 12-Gy fractions totaling 36 Gy for the liver
lesions, and 18 Gy in a single fraction for the spine
lesions, respectively.
Dosimetric evaluation parameters and statistical analysis
Each treatment plan was evaluated with respect to target
coverage criteria and OAR sparing criteria. For targets, the
mean PTV doses, as well as the minimum and maximum
doses to the PTVs, were compared. The maximum dose
(Dmax) was defined as the maximum dose value that cov-
ers 1% of the target volume (i.e. D1) and the minimum
dose (Dmin) was defined as the minimum dose value that
covers 99% of the target volume (i.e. D99). The dosimetric
metrics for the OARs were Dmax, Dmean, D5 and D1 for the
brainstem; Dmean, D10 and D30 for the liver; and Dmax,
Dmean and D10 for the spine cases, respectively.
We generalized the shape into two basic categories: the
round/ellipsoidal shapes which are representative of all
the targets in the brain and the liver group, and the con-
cave shapes which are representative of all the spine cases,
as shown in figure 1. We also generalized the volumes
into two major categories, the small volume sizes which
are generally seen in the intracranial group and the large
volume sizes which are generally seen in the extracranial
group, as shown in Additional file 1.
Both the treatment technique and the MLC system can
impact the dosimetric outcome for the brain and the liver
groups. Therefore, the Generalized Estimating Equation
technique (GEE) [26,27] was used to separate their indi-
vidual influences and to analyze their interactions for
dosimetry outcomes. The analysis started by testing for
the two-factor interaction, followed either by testing for
the individual factor effect if no interaction was detected
at critical value of 0.05, or by conducting the pair-wise
group comparison if the interaction was significant at the
0.05 level. For the spine lesions, a paired-t test was per-
formed to evaluate the difference between the HD120
MLC and the standard MLC on dosimetric parameters for
IMRT.
Results
PTV coverage
For each case, the PTV coverage was essentially equivalent
among different plans. Additional file 2 lists the dosimet-
ric indices for all cases. The small standard deviations for
all plans indicate consistency in applying the treatment
techniques to achieve the optimal dose coverage; i.e., the
prescription isodose covered at least 97% of the target vol-
ume and the dose heterogeneity inside the target was kept
at about 10%. For each individual case, the Dmin was
within 2% and Dmax was within 2.5% among different
plans. Using the 3D treatment technique with standard
MLC as baseline, Figure 2 displays the percentage differ-
ence between plans using other treatment techniques and
the HD120 MLC system and the baseline plans.
Compared to the standard MLC system, the HD120 MLC
improved the dose homogeneity for the brain group, with
larger Dmin (p < 0.01) and smaller Dmax (p < 0.01). In con-
trast, the HD120 MLC had no significant impact on Dmin,
Dmax, or Dmean values for either the liver group or the spine
group. The use of intensity modulation also significantly
reduced the Dmax values for the liver group (p <0.01).
Although statistically significant, all the above differences
were quite small (< 2%) and may likely have little clinical
significance.
OAR dose sparing
Again, using the 3D treatment technique with the stand-
ard MLC as the baseline, Figure 3 displays the percentage
difference between the baseline and plans using other
treatment techniques and/or the HD120 MLC system
For the brain group, the HD120 MLC and the use of inten-
sity modulation contributed jointly to dose sparing of the
brainstem, as a positive interaction of these two factors
was detected with GEE (p = 0.003). First, the intensity
modulation technique showed significant sparing for the
brainstem, compared to other treatment techniques
(Additional file 3). Specifically, IMRT produced the great-
est dose reduction in the high-dose region, as reflected by
the D1 and D5 doses. The reduction in D1 was about 10%
and 9%, and in D5 was about 18% and 14%, when 3D and
DARC techniques, respectively, were replaced by the IMRT
technique. Secondly, for the IMRT technique the HD120
MLC also reduced all brainstem doses (p = 0.04) relative
to the standard MLC. The improved field shaping with the
HD120 MLC also helped to reduce the D5 dose for all
techniques by 3 – 9% (p = 0.003). Third, the HD120 MLC
combined with IMRT jointly benefited dose reduction in
the middle dose range, reflected by the D10 dose, (p =
0.001). As a result, the mean dose to the brainstem wasRadiation Oncology 2009, 4:3 http://www.ro-journal.com/content/4/1/3
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The percentage difference of PTV coverage between plans using other treatment techniques and MLC systems and the baseline  plans, the 3D treatment technique with standard MLC Figure 2
The percentage difference of PTV coverage between plans using other treatment techniques and MLC sys-
tems and the baseline plans, the 3D treatment technique with standard MLC.
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The percentage difference of OAR sparing between plans using other treatment techniques and MLC systems and the baseline  plans, the 3D treatment technique with standard MLC Figure 3
The percentage difference of OAR sparing between plans using other treatment techniques and MLC systems 
and the baseline plans, the 3D treatment technique with standard MLC.
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reduced by 35%, between the best (IMRT with the HD120
MLC) and the worst (3D with standard MLC) plans.
Similarly, the HD120 MLC and the IMRT techniques con-
tributed jointly to the dose sparing for the liver group
(Additional file 4). The HD120 MLC reduced doses at
both D10 and D30, as well as the mean dose (p < 0.01). The
dose reduction (at all levels) attributable to the HD120
MLC was between 3 – 5% with the 3D and DARC tech-
niques and between 1 – 2% with the IMRT technique.
When comparing treatment techniques, IMRT plans were
significantly better than either 3D or DARC plans. The
IMRT technique improved the dose sparing at all levels, as
the D10, D30 and Dmean indices were reduced by over 12%
over the 3D/DARC techniques.
For the spine group, using the HD120 MLC substantially
improved cord sparing (p < 0.01) as the ability to map the
dose to the concave-shaped target improved (Additional
file 5). Figure 4 displays dose distribution for a spine case.
As shown, the dose fall off is much steeper at the target-
cord junction for the smaller leaves. The overall dose
reduction was 14%, 19% and 29% for the D1, D10 and
Dmean dose indices, respectively.
Effect of target shape and volume size
The effect of target volume was compared with the brain
and the liver group. As stated earlier, the targets were in
general round or ellipsoidal for both the brain and liver
lesions, and the most significant differences between
these two groups were the target and OAR volumes. The
lesions in the brain were several times smaller than those
in the liver, and the size of the brainstem was also several
times smaller than the liver. The dose reduction (combin-
ing all levels) contributed by the HD120 MLC decreased,
from 4 – 11% to 1 – 5%, as target sizes increased from the
brain group to the liver group.
The effect of target shape was compared with the spine
and the liver group. While the target volumes were similar
for the liver and the spine groups, the target shapes were
much more complex in the spine group (concave vs.
round or ellipsoidal for the liver). In contrast to the mod-
erate contribution for liver lesions, the HD120 MLC sig-
nificantly improved cord sparing for the spine group. By
using the 120HD MLC, the dose to the cord was reduced
on average by 19% to 14% at high to middle dose levels
(D1 to D10, respectively) for the spine plans.
Discussion
This study was designed to provide similar target coverage
for all plans. The prescription dose was set to the isodose
line at the periphery of the PTV that covered at least 97%
of the target for all plans. Using this strategy, the DVH to
the target volumes was very similar using different treat-
ment planning techniques, yielding dose indices that var-
ied less than 2.5% for the same lesion.
The results from this study suggested that the degree of
improved organ sparing varied with target size and shape.
The targets in the brain and liver groups are similar in
shape (round or ellipsoidal) differed substantially in vol-
ume (small vs. large). The lesions in the brain were several
times smaller than those in the liver, and the volume of
the brainstem was also several times smaller than that of
the liver itself. The HD120 MLC yields a better match of
the beam aperture to the target projection; however, its
benefits become less noticeable as the target/OAR
becomes larger. Therefore, the dose reduction contributed
by the HD120 MLC decreased, from 4 – 11% to 1 – 5%,
as target sizes increased between the brain and liver
groups. On the other hand, the targets in the liver and
spine groups were of roughly the same size but fell into
different shape groups (round vs. concave, respectively).
The concave lesion shape presented a challenge for con-
ventional techniques to provide adequate target coverage
and optimal organ sparing. Clinically, all spine SBRT
lesions in our institution are planned with IMRT, owing to
the ability to manipulate the intensity at virtually the
voxel level using this technique. Since spinal cords were
always adjacent to the target volume, the ability to manip-
ulate the radiation beam with greater precision via the
high-definition MLC leaves helped reduce the doses the
cord received. Therefore, in contrast to the moderate ben-
efit for liver lesions, the HD120 MLC significantly
improved cord sparing for the spine group, realizing a
14%–19% dose reduction in D1 and D10, respectively.
Conclusion
The finer HD120 MLC in combination with IMRS pro-
vides significant dosimetric benefits for SRS/SBRT. Spar-
ing of the OARs is dependent on the lesion and critical
organ size and shape complexity. Small lesions (such as
brain lesions treated with SRS) and complex target/OAR
geometry (such as the spine lesions encountered in SBRT)
will benefit most from the finer-leaf collimator and treat-
ment planning capabilities provided by a dedicated radi-
osurgery system, compared to larger and more rounded or
regularly shaped target volumes. Prospective clinical trials
with comprehensive data collection should be conducted
to determine whether these dosimetric advantages trans-
late into clinically significant benefits.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors read and approved the final manuscript.Radiation Oncology 2009, 4:3 http://www.ro-journal.com/content/4/1/3
Page 8 of 10
(page number not for citation purposes)
Example dose distribution of a spine case, IMRT plans with (a) standard MLC system and (b) with HD120 MLC system Figure 4
Example dose distribution of a spine case, IMRT plans with (a) standard MLC system and (b) with HD120 MLC 
system. The black circles indicate the regions where dose fall off being significantly different between the two plans.
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